Related references
Note: Only part of the references are listed.New French heart allocation system: Comparison with Eurotransplant and US allocation systems
Richard Dorent et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
The introduction of a super-urgent heart allocation scheme in the UK: A 2-year review
Sally Rushton et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Practice Changes at US Transplant Centers After the New Adult Heart Allocation Policy
William F. Parker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
Raymund R. Razonable et al.
CLINICAL TRANSPLANTATION (2019)
Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation
Stephanie Pons et al.
ANNALS OF INTENSIVE CARE (2019)
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match
Daniel C. Chambers et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)
Is this critically ill patient immunocompromised?
Frederic Pene et al.
INTENSIVE CARE MEDICINE (2016)
Survival after heart transplantation for non-metastatic primary cardiac sarcoma
Hua Li et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2016)
Impact of Rabbit Antithymocyte Globulin Dose on Long-term Outcomes in Heart Transplant Patients
Arezu Z. Aliabadi et al.
TRANSPLANTATION (2016)
n Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
Hallvard Holdaas et al.
JOURNAL OF TRANSPLANTATION (2016)
Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression
Andreas Zuckermann et al.
TRANSPLANT INTERNATIONAL (2015)
Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial
A. K. Andreassen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Report from a consensus conference on primary graft dysfunction after cardiac transplantation
Jon Kobashigawa et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2014)
Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial
H. J. Eisen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation
Gerald J. Berry et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2013)
Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion
James W. Hart et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies
Vilborg Sigurdardottir et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
Creation of a Quantitative Recipient Risk Index for Mortality Prediction After Cardiac Transplantation (IMPACT)
Eric S. Weiss et al.
ANNALS OF THORACIC SURGERY (2011)
Immunological risk factors for infection after immunosuppressive and biologic therapies
Javier Carbone et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes
Jon A. Kobashigawa et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
Maria Rosa Costanzo et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Extracorporeal photopheresis: Past, present, and future
Robert Knobler et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Calcineurin-inhibitor minimization protocols in heart transplantation
Andreas Oliver Zuckermann et al.
TRANSPLANT INTERNATIONAL (2009)
Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure
Francisco Gonzalez-Vilchez et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
New immunosuppressive strategies and the risk of infection
N. J. Mueller
TRANSPLANT INFECTIOUS DISEASE (2008)
Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: The role of extracorporeal photopheresis
Lucio Urbani et al.
JOURNAL OF CLINICAL APHERESIS (2007)
Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. Cyclosporine with MMF in cardiac transplant patients: 1-year report
JA Kobashigawa et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients -: A large European trial
M Grimm et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Rejection with hemodynamic compromise: Objective evidence for efficacy of photopheresis
JK Kirklin et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2006)
Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection
S Stewart et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Risk factors affecting survival in heart transplant patients
L Almenar et al.
TRANSPLANTATION PROCEEDINGS (2005)
First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation
B Meiser et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation
ML Barr et al.
CLINICAL TRANSPLANTATION (2000)
Pre- and early postoperative risk factors for death after cardiac transplantation: A single center analysis
AO Zuckermann et al.
TRANSPLANT INTERNATIONAL (2000)
Share Paper
